Abstract
Purpose
The pathological mechanism of lumbar spinal stenosis is reduced blood flow in nerve roots and degeneration of nerve roots. Exercise and prostaglandin E1 is used for patients with peripheral arterial disease to increase capillary flow around the main artery and improve symptoms; however, the ankle-brachial index (ABI), an estimation of blood flow in the main artery in the leg, does not change after treatment. Lumbar spinal nerve roots contain somatosensory, somatomotor, and unmyelinated autonomic nerves. Improved blood flow by medication with prostaglandin E1 and decompression surgery in these spinal nerve roots may improve the function of nerve fibers innervating muscle, capillary, and main vessels in the lower leg, resulting in an increased ABI. The purpose of the study was to examine whether these treatments can improve ABI.
Materials and Methods
One hundred and seven patients who received conservative treatment such as exercise and medication (n=56) or surgical treatment (n=51) were included. Low back pain and leg pain scores, walking distance, and ABI were measured before treatment and after 3 months of conservative treatment alone or surgical treatment followed by conservative treatment.
Compression of spinal nerve roots by lumbar spinal stenosis (LSS) is a major clinical problem associated with intermittent claudication, pain, numbness, and lack of normal sensitivity. Such compression has been shown to induce neurophysiologic dysfunction, degeneration, and reduced blood flow in nerve roots in animal models and humans.1,2
Reduced blood flow in nerve roots induces neurogenic intermittent claudication, and drugs for the improvement of blood flow in nerve roots have been developed. Prostaglandin E1 (PGE1) causes vasodilation in both arterioles and venules.3,4 In a clinical study, intravenous lipo-PGE1 administered for 10 consecutive days to 40 patients produced symptomatic improvement for a limited period in the treatment of neurogenic intermittent claudication associated with lumbar spinal stenosis.5 An investigation of 25 cases of lumbar spinal stenosis by myeloscopy revealed that the diameters of blood vessels in the cauda equina differed significantly from those in a control group.6
In addition to medication, several therapies may increase blood flow into spinal nerves. In animal studies and clinical trials, lumbar spinal canal stenosis has been treated by electrical acupuncture on the pudendal nerve and at the nerve root.7 After stimulation, immediate and sustained pain relief was observed in patients and an increase in sciatic nerve blood flow was observed.7 Changes in the microcirculation in the L5 and S1 nerve roots have also been examined in patients with lumbar spinal stenosis during lumbar interbody fusion surgery by endoscopy.8 Blood flow significantly decreased after nerve compression and stretching. These findings indicate that damage of spinal nerve roots induces decreased blood flow into the nerve roots, and results in pain.8
Patients with peripheral arterial disease (PAD) may be asymptomatic or may present with a spectrum of symptoms including atypical leg pain, classic claudication, rest pain, and critical limb ischemia with gangrene.9 PAD is diagnosed based on the ankle-brachial blood pressure index (ABI), a rapid and simple non-invasive diagnostic technique.9 ABI reflects blood flow in the main artery in the leg. Exercise and drugs such as PGE1 improve the symptoms of PAD,9 generally by increasing flow in capillary vessels without having an effect on the main arterial tract. Thus, most reports have shown that these therapies improve symptoms, but do not influence ABI.10,11
The lumbar spinal ventral nerve roots include somatic and autonomic nerves such as the unmyelinated sympathetic and parasympathetic nerves that innervate the lower leg.12-14 Therefore, we hypothesized that treatment with therapies such as exercise, medication, and surgery would increase blood flow on the surface of compressed and damaged spinal nerves or that functional recovery of spinal nerves could be achieved by decompression surgery. Subsequently, these therapies should improve the function of somatosensory, motor and autonomic nerves innervating the main artery in the lower leg and lead to an increase in ABI. However, after therapy for lumbar spinal stenosis, improvement of blood flow in the main artery in the lower leg has not been previously examined. Therefore, the purpose of this study was to investigate the effects of these therapies on symptoms of lumbar spinal stenosis and on ABI.
The ethics committee at our institution approved the protocol for the human procedures used in this study. Informed written consent was obtained from each subject.
One hundred and seven patients with low back and leg pain that had continued for at least 1 month were included. Patients who had previously undergone spinal surgery were excluded from the study. We also excluded patients with spinal tumor, infection, or trauma. Lumbar spinal stenosis was diagnosed using X-rays, magnetic resonance imaging (MRI) and by physical examination by spine surgeons. In the MRI, the degree of spinal stenosis varied from slight to severe. In addition, central stenosis, stenosis of the lateral recess, and foraminal stenosis were apparent. Patients with monoradiculopathy, polyradiculopathies, or cauda equine syndrome were included in the study.
Patients were divided into groups that received conservative and surgical treatment, respectively. Conservative therapy group was applied in patients who did not undergo any therapy before visiting hospital. Surgery was used for patients in whom previous conservative treatment was ineffective. Therefore, seriously impaired patients underwent surgery and the less impaired patients underwent conservative care.
In the conservative therapy group, treatment included exercise (walking, walking in a pool, muscle training, and muscle stretching), medication, and an epidural block. Without the help of a therapist, patients walked above ground and in a pool. Muscle training and stretching were performed for the abdominal and lower extremities with the assistance of physical therapists. Medication included NSAIDs, vitamins, muscle relaxants, and PGE1, as determined by the personal physician for each patient. A transforaminal or caudal epidural block was administered in some patients, and exercise, drugs, and blocks were used in some cases. ABI was measured before and 3 months after conservative treatment. Before measuring ABI, patients had not received therapy.
For the surgery group, ABI was measured before and 3 months after surgery. Before surgery, patients had undergone exercise therapy, medication, and epidural block. After surgery, these patients also received exercise therapy and medication, but were not given an epidural block.
The JOA Back Pain Evaluation Questionnaire (JOABPEQ: including low back pain, lumbar function, walking ability, social life function and mental health) and a visual analogue scale (VAS; from 0 to 100, 100=worst pain) were evaluated for each patient. The range of the JOABPEQ score for each domain is 0 to 100, with higher scores indicating a better condition. The five functional scores were used independently. Maximum walking distance without rest, total walking distance in a day, low back pain, and leg pain were evaluated before and 3 months after treatment.
Systolic blood pressures in the brachial, anterior and posterior tibial arteries were measured using inflatable cuffs and a Doppler probe. The maximum ankle arterial pressure was divided by the maximum brachial arterial pressure to calculate the ABI. ABI was measured according to the Transatlantic Inter Society Consensus (TASC II) guidelines for management of PAD.15
This study was performed to investigate the effects of different therapies on symptoms of lumbar spinal stenosis and on ABI, but not to investigate differences in the effects among therapies. Therefore, comparisons before and after treatment were performed in each group, but a comparison between the conservative and surgical groups was not performed.
Patient characteristics are shown in Table 1. Age ranged from 39 to 80 years old, with average ages of 68.04±9.11 and 67.00±9.03 years old in the conservative and surgical groups, respectively (mean±SD). Among all patients, 19.6% in the conservative group and 17.6% in the surgical group were smokers. Complications included diabetes, hyperlipidemia, hypertension, and vascular occlusion (cerebral, coronary, and peripheral) in both groups.
Treatment given over 3 months in the two groups is shown in Table 2. In the conservative group, the patients received exercise therapy (35%), medications (100%), and epidural block (22%). PGE1 was the most common drug (96.5%) and NSAIDs, vitamins, and muscle relaxants were also used. A transforaminal (17.9%) or caudal (3.6%) epidural block was administered for low back pain or leg pain. In the surgical group, patients received exercise therapy (50%) and medication (100%) during the 3 months after surgery. Epidural block (20%) was given only before surgery. Forty patients underwent decompression surgery and 11 underwent decompression and posterior fusion surgery. There were no perioperative complications. In the conservative group, no patients underwent surgery for severity of symptoms during the 3-month study period.
In the conservative group, VAS scores for low back pain, buttock pain, and leg pain showed significant improvements after treatment (p<0.01) (Table 3). JOABPEQ scores in all five categories (low back pain, lumbar function, walking ability, social life function, and mental health) (Table 3) also significantly improved after 3 months of conservative treatment (low back pain: p<0.001, lumbar function; p=0.004, walking ability: p=0.001, social life function: p<0.001, and mental health: p<0.001). There was also a significant improvement in maximum walking distance without rest after treatment (p=0.009) (Table 3). In the surgical group, the VAS scores for low back pain, buttock pain, and leg pain showed significant improvements after surgery (p<0.001) (Table 4). JOABPEQ scores in all categories were also significantly improved at 3 months after surgery (p<0.001), and there was a significant improvement in walking distance in one day (p=0.003) (Table 4).
In the current study, both conservative and surgical treatment improved low back pain, leg pain, walking difficulty that originated from lumbar spinal stenosis, and increased ABI. These findings suggest that conservative and surgical treatment increase blood flow in the anterior and posterior tibial arteries.
Most patients treated conservatively received PGE1, a vasodilator that increases blood flow and inhibits platelet aggregation.3 Intravenous PGE1 is primarily used for chronic peripheral arterial occlusive diseases in the United States and Europe.3 PGE1 also increases blood flow at the surface of spinal nerve roots. Thus, PGE1 analogs have been developed to treat symptoms of lumbar spinal stenosis.3,16 Matsudaira, et al.17 compared limaprost with etodolac, an NSAID, in 66 patients in a randomized control trial. After eight weeks, subjects receiving limaprost had better scores on the Standard Form-36 subscales for physical function, physical role, bodily pain, vitality, and mental health, and greater improvements for walking distance, leg numbness, and patient satisfaction.17 In the current study, surgical treatment also improved symptoms. Kovacs, et al.18 reviewed RCTs comparing any form of conservative and surgical treatment based on a search of the CENTRAL, Medline, EMBASE and TripDatabase databases. In patients with symptomatic LSS, implantation of a specific device or decompressive surgery, with or without fusion, were found to be more effective than continued conservative treatment when the latter had failed for 3-6 months. In the current study, we did not compare conservative treatment with surgical treatment; however, both improved symptoms after a 3-month period.
PAD is diagnosed by assessment of ABI, and ABI reflects blood flow in the main artery in the leg.8 Exercise and drugs such as PGE1 and cilostazol improve the symptoms of PAD8 and also improve the maximal walking distance by 40% to 60%.19,20 These therapies generally increase flow in capillary vessels and do not affect the main arterial tract. For this reason, most reports have shown that these drugs do not improve ABI.10,11 However, Mohler, et al.21 found that treatment of PAD with cilostazol significantly improved ABI, although with the conclusion that the mechanism was unclear. In the current study, ABI increased after conservative and surgical treatment for lumbar spinal stenosis. We propose the following explanation of these results. Symptoms in lumbar spinal stenosis are caused by compression of the spinal nerve roots in animal models and humans.1,2 Spinal ventral nerve roots contain unmyelinated nerve fibers associated with sensory and autonomic nerves, and myelinated nerve fibers associated with motor fibers.12-14 In addition, somatosensory, somatomotor, and autonomic nerve fibers run on the surface of spinal nerves and the dura mater.14 Animal and human cadaver studies have shown that lumbar and sacral spinal ventral nerve roots contain many unmyelinated nerve fibers and sympathetic and parasympathetic nerves that innervate blood vessels in the lower leg,12,13 with no significant difference in the proportions of unmyelinated nerve fibers among sympathetic (T11-L2), parasympathetic (S2) and other (C4-T10 and L3-S1) segments.13 These sympathetic and parasympathetic nerve fibers innervate the main artery in the lower leg. Sympathetic and parasympathetic nerve fibers may be damaged and compressed in patients with lumbar canal stenosis. This dysfunction is improved after conservative therapy or surgery, and this results in functional recovery the autonomic nervous system. Thus, this may explain the increase in ABI after treatment in the current study.
There were several limitations in the study. First, we did not compare conservative and surgical treatment. Second, a normal ABI falls in the range of 0.91-1.30, while a low ABI at rest (<0.90) indicates a high risk of PAD.22 In the current study, most patients had ABI in the normal range and the clinical significance of an increase of ABI in this population is questionable. Third, in the surgical group, patients used PGE1 and other drugs after surgery, so there was possibility that PGE1 and other drugs influenced the outcome in the surgical group. Therefore, further studies are needed to test our hypothesis more rigorously.
In conclusion, ABI was measured before and 3 months after treatment in 107 patients with LSS. ABI was significantly increased after both conservative and surgical treatment. We concluded that improved function of sympathetic and parasympathetic nerves in spinal nerve roots innervating the lower leg may increase blood flow in the main artery of the leg.
References
1. Konno S, Yabuki S, Sato K, Olmarker K, Kikuchi S. A model for acute, chronic, and delayed graded compression of the dog cauda equina. Presentation of the gross, microscopic, and vascular anatomy of the dog cauda equina and accuracy in pressure transmission of the compression model. Spine (Phila Pa 1976). 1995; 20:2758–2764.
2. Sekiguchi M, Kikuchi S, Myers RR. Experimental spinal stenosis: relationship between degree of cauda equina compression, neuropathology, and pain. Spine (Phila Pa 1976). 2004; 29:1105–1111.
3. Müller B, Schmidtke M, Witt W. Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch. Prostaglandins Leukot Med. 1987; 29:187–198.
4. Takahashi K, Olmarker K, Holm S, Porter RW, Rydevik B. Double-level cauda equina compression: an experimental study with continuous monitoring of intraneural blood flow in the porcine cauda equina. J Orthop Res. 1993; 11:104–109.
5. Murakami M, Takahashi K, Sekikawa T, Yasuhara K, Yamagata M, Moriya H. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication. J Spinal Disord. 1997; 10:499–504.
6. Ooi Y, Mita F, Satoh Y. Myeloscopic study on lumbar spinal canal stenosis with special reference to intermittent claudication. Spine (Phila Pa 1976). 1990; 15:544–549.
7. Inoue M, Kitakoji H, Yano T, Ishizaki N, Itoi M, Katsumi Y. Acupuncture Treatment for Low Back Pain and Lower Limb Symptoms-The Relation between Acupuncture or Electroacupuncture Stimulation and Sciatic Nerve Blood Flow. Evid Based Complement Alternat Med. 2008; 5:133–143.
8. Dezawa A, Unno K, Yamane T, Miki H. Changes in the microhemodynamics of nerve root retraction in patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976). 2002; 27:2844–2849.
9. Ferreira AC, Macedo FY. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management. Ann Med. 2010; 42:139–150.
10. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H. Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers. Am J Nephrol. 2006; 26:462–468.
11. Sasamura H, Kitamura Y, Nakamura M, Ryuzaki M, Saruta T. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension. Clin Exp Hypertens. 2006; 28:511–520.
12. Karlsson M, Hildebrand C, Warnborg K. Fibre composition of the ventral roots L7 and S1 in the owl monkey (Aotus trivirgatus). Anat Embryol (Berl). 1991; 184:125–132.
13. Ko HY, Shin YB, Sohn HJ, Chang JH, Ahn YH, Ha YH. Unmyelinated fibers in human spinal ventral roots: C4 to S2. Spinal Cord. 2009; 47:286–289.
14. Konnai Y, Honda T, Sekiguchi Y, Kikuchi S, Sugiura Y. Sensory innervation of the lumbar dura mater passing through the sympathetic trunk in rats. Spine (Phila Pa 1976). 2000; 25:776–782.
15. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45:Suppl S. S5–S67.
17. Matsudaira K, Seichi A, Kunogi J, Yamazaki T, Kobayashi A, Anamizu Y, et al. The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. Spine (Phila Pa 1976). 2009; 34:115–120.
18. Kovacs FM, Urrútia G, Alarcón JD. Surgery versus conservative treatment for symptomatic lumbar spinal stenosis: a systematic review of randomized controlled trials. Spine (Phila Pa 1976). 2011; 36:E1335–E1351.
19. Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE Jr, Bortey EB, et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med. 1999; 159:2041–2050.
20. Strandness DE Jr, Dalman RL, Panian S, Rendell MS, Comp PC, Zhang P, et al. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002; 36:83–91.